started · updated
Researchers identify potential blood test for living CTE diagnosis
New research published in JAMA suggests a blood test may have the potential to detect advanced stages of chronic traumatic encephalopathy (CTE) in living individuals. Historically, the degenerative brain disease, which is linked to repeated head impacts in contact sports, could only be diagnosed after death through autopsy.
One study involving former American football players identified a specific protein marker in blood samples that correlated with advanced-stage CTE confirmed by post-mortem brain examinations. While researchers described the finding as a potential “game changer,” the test currently shows promise primarily for identifying advanced stages rather than early-stage pathology.
A separate systematic review and meta-analysis published in JAMA Network Open found that CTE pathology is rare in individuals without a documented history of contact sports. The review, which analyzed 12 studies involving 4,421 deceased individuals, found CTE in only 0.66% of community brain bank donors. Despite its rarity in non-athletes, researchers suggest that if these rates are extrapolated, more than 1 million Americans could be living with the disease, highlighting the need for effective diagnostic tools.
Entities
Banner Health · Boston University · JAMA Network Open · Mass General Brigham · Michael Alosco